Skip to main content
logo
IMPACT Therapeutics, Inc (HKG:7630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
42.60
+2.70 (6.77%)
Jun 1, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Research, Development & Commercialisation of Pharmaceutical Products
38.25M33.55M
Research, Development & Commercialisation of Pharmaceutical Products Growth
14.02%-
Total
38.25M33.55M
Total Growth
14.02%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Chinese Mainland
20.25M-
USA
18.00M33.55M
USA Growth
-46.33%-
Total
38.25M33.55M
Total Growth
14.02%-
Source: S&P Global Market Intelligence.